Trial Profile
A Phase 1b, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Single-Dose of ABT-614 and the Effect of ABT-614 on Glomerular Filtration Rate in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Albuminuria
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Feb 2014
Price :
$35
*
At a glance
- Drugs ABT-614 (Primary)
- Indications Substance-related disorders
- Focus Pharmacokinetics
- Sponsors Abbott Laboratories
- 10 Feb 2014 New trial record